These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nephrogenic diabetes insipidus in a patient taking cidofovir. Schliefer K; Rockstroh JK; Spengler U; Sauerbruch T Lancet; 1997 Aug; 350(9075):413-4. PubMed ID: 9259663 [No Abstract] [Full Text] [Related]
9. More new drugs for HIV and associated infections. Med Lett Drugs Ther; 1997 Feb; 39(994):14-6. PubMed ID: 9040649 [No Abstract] [Full Text] [Related]
11. SOCA research group stops enrollment. Studies of the Ocular Complications of AIDS. AIDS Patient Care STDS; 1996 Jun; 10(3):188. PubMed ID: 11361634 [No Abstract] [Full Text] [Related]
12. Severe irreversible proximal renal tubular acidosis and azotaemia secondary to cidofovir. Kay TD; Hogan PG; McLeod SE; Johnson DW Nephron; 2000 Nov; 86(3):348-9. PubMed ID: 11096296 [No Abstract] [Full Text] [Related]
13. Uveitis in HIV positive patients. Cunningham ET Br J Ophthalmol; 2000 Mar; 84(3):233-5. PubMed ID: 10684829 [No Abstract] [Full Text] [Related]
14. NDA filed to treat refractory herpes. AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756 [No Abstract] [Full Text] [Related]
15. FDA grants marketing clearance of Vistide for the treatment of CMV retinitis. AIDS Patient Care STDS; 1996 Dec; 10(6):383-4. PubMed ID: 11361576 [No Abstract] [Full Text] [Related]
16. Cidofovir approved. PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898 [TBL] [Abstract][Full Text] [Related]
18. From the Food and Drug Administration. Nightingale SL JAMA; 1995 Oct; 274(14):1109. PubMed ID: 7563473 [No Abstract] [Full Text] [Related]
19. Gilead announces phase I/II data insufficient for marketing clearance of FORVADE topical gel to treat refractory herpes in patients with AIDS. AIDS Patient Care STDS; 1997 Aug; 11(4):293. PubMed ID: 11361852 [No Abstract] [Full Text] [Related]